Enovis (ENOV) EPS (Diluted) Growth (3y) (2013 - 2026)
Enovis (ENOV) EPS (Diluted) Growth (3y) (2013 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Diluted) Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | -6.43% |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | 7.66% |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 3.09% |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | 62.91% |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | - |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | 63.42% |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | 30.57% |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | 29.56% |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | - |
| 10 | Enovis | 1.50 Bn | 1.47 Bn | 365.49 Mn | 50.88% |
Historic Data
Download Data| Date | Value |
|---|---|
| Apr 3, 2026 | 50.88% |
| Dec 31, 2025 | -27.98% |
| Oct 3, 2025 | 58.42% |
| Jul 4, 2025 | 87.33% |
| Apr 4, 2025 | -26.16% |
| Dec 31, 2024 | -69.57% |
| Sep 27, 2024 | -56.25% |
| Jun 28, 2024 | -26.04% |
| Dec 31, 2023 | 26.02% |
| Sep 29, 2023 | 1.50% |
| Jun 30, 2023 | 35.24% |
| Mar 31, 2023 | -27.25% |
| Dec 31, 2022 | 31.53% |
| Sep 30, 2022 | -26.88% |
| Jul 1, 2022 | 57.29% |
| Apr 1, 2022 | 30.79% |
| Dec 31, 2021 | -2.40% |
| Oct 1, 2021 | 0.81% |
| Jul 2, 2021 | 78.91% |
| Apr 2, 2021 | 26.32% |